Leflunomide 20 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2002-07-01
Target enrollment:
Participant gender:
Summary
This study will compare the relative bioavailability (rate and extent of absorption) of 20 mg
Leflunomide Tablets by TEVA Pharmaceuticals Industries, Ltd. with that of 20 mg ARAVA™
Tablets by Aventis Pharmaceuticals, Inc. following a single oral dose (1 x 20 mg tablet) in
healthy adult subjects under fasting conditions.